UPDATED: NPA calls decision a "win for the industry and consumers"
‘A drug-level randomized controlled clinical trial for a supplement has never been the standard’: Bayer ‘gratified’ with court decision vs FTC
The hotly anticipated decision in the dispute between Bayer and the US Federal Trade Commission over claims in support of Phillips’ Colon Health is in, with a judge ruling in favor of the company.